Cargando…
Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy
Introduction: Intensive oncological treatment integrated with resection of metastases raised the clinical outcome of metastatic colorectal cancer (MCRC). In clinical practice, complex evaluation of clinical (age, performance status, comorbidities), and biological (tumoral genotype, pharmacogenomic)...
Autores principales: | Bruera, Gemma, D'Andrilli, Antonio, Simmaco, Maurizio, Guadagni, Stefano, Rendina, Erino Angelo, Ricevuto, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417602/ https://www.ncbi.nlm.nih.gov/pubmed/32850329 http://dx.doi.org/10.3389/fonc.2020.01155 |
Ejemplares similares
-
Parenchymal Sparing Surgery for Lung Cancer: Focus on Pulmonary Artery Reconstruction
por: Menna, Cecilia, et al.
Publicado: (2022) -
Stenting treatment is a minimally traumatic and effective alternative to surgical repair for iatrogenic tracheobronchial lesion
por: D’Andrilli, Antonio, et al.
Publicado: (2020) -
Commentary: Extended resection for radical treatment of advanced-stage thymoma can result in resolution of severe myasthenia crisis refractory to medical therapy
por: D'Andrilli, Antonio, et al.
Publicado: (2020) -
Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments
por: Bruera, Gemma, et al.
Publicado: (2020) -
Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen
por: BRUERA, GEMMA, et al.
Publicado: (2014)